Just published @RetinalPhys: #Suprachoroidal Drug Delivery Technology. After #Xi…
[ad_1]
Just published @RetinalPhys: #Suprachoroidal Drug Delivery Technology. After #Xipere’s approval, SC #drugdelivery is clinical reality.
4 therapies delivered SC are in #clinicaltrials: a corticosteroid, a TKI, a #genetherapy & a virus-like drug conjugate.
https://t.co/ZkPAafykHA
[ad_2]
Source by Thomas Ciulla, MD, MBA